These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8368048)

  • 41. Biologic therapy of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; Gutterman J
    Oncology (Williston Park); 1987 Sep; 1(7):35-40, 48-9, 52. PubMed ID: 3152810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of interferon in the treatment of chronic myelogenous leukemia.
    Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):3-7. PubMed ID: 7992097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia.
    Terebelo HR
    Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
    Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
    Kantarjian HM; Keating MJ; Estey EH; O'Brien S; Pierce S; Beran M; Koller C; Feldman E; Talpaz M
    J Clin Oncol; 1992 May; 10(5):772-8. PubMed ID: 1569449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; O'Brien S; Beran M; Koller C; Pierce S; Kornblau S; Estey E; Keating MJ; Talpaz M
    Leukemia; 1997 Oct; 11(10):1610-6. PubMed ID: 9324278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia.
    Beck JR; Guilhot J; Giles FJ; Aoki N; Wirt DP; Guilhot F
    Leuk Lymphoma; 2001 Mar; 41(1-2):117-24. PubMed ID: 11342363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha interferon: progress and perspectives in the biotherapy of chronic myelogenous leukemia.
    Habermann TM
    Oncol Nurs Forum; 1989; 16(6 Suppl):8-11. PubMed ID: 2687814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - clinical benefits.
    Lindauer M; Fischer T
    Leuk Lymphoma; 2001 May; 41(5-6):523-33. PubMed ID: 11378570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of chronic myelogenous leukaemia with interferons.
    Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
    Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia.
    Arthur CK; Ma DD
    Acta Haematol; 1993; 89 Suppl 1():15-21. PubMed ID: 8475667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
    Baccarani M; Rosti G; de Vivo A; Bonifazi F; Russo D; Martinelli G; Testoni N; Amabile M; Fiacchini M; Montefusco E; Saglio G; Tura S;
    Blood; 2002 Mar; 99(5):1527-35. PubMed ID: 11861264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of chronic myelogenous leukemia in the interferon era.
    Giralt S; Kantarjian H; Talpaz M
    Semin Hematol; 1995 Apr; 32(2):152-8. PubMed ID: 7652582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular diagnosis and therapeutic strategy for Philadelphia chromosome-positive acute leukemia].
    Kawakubo K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):261-6. PubMed ID: 8158846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia.
    Millot F; Brice P; Philippe N; Thyss A; Demeoq F; Wetterwald M; Boccara JF; Vilque JP; Guyotat D; Guilhot J; Guilhot F
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):18-22. PubMed ID: 11902732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB; Wolska-Smoleń T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group.
    Guilhot F
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):24-5. PubMed ID: 8235700
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
    Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The 6M 12M trial--study of the effectivess and tolerance of treatment in chronic myeloid leukaemia with a combination of interferon alfa and cytarabine].
    Tóthová E; Fricová M; Stecová N; Svorcová E; Guman T; Rraffac S; Kafková A; Hlebasková M
    Vnitr Lek; 2000 Jul; 46(7):391-4. PubMed ID: 15635799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon alfa as primary treatment of chronic myeloid leukemia: long-term follow-up of 71 patients observed in a single center.
    Kloke O; Opalka B; Niederle N
    Leukemia; 2000 Mar; 14(3):389-92. PubMed ID: 10720131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.